RxDoctor Payments Data

Stephanie Garza

Family · Chandler, AZNPI 1265080477

Payments from drug & device makers

$2,052in general payments, 2019–2025

Across 149 payments — averaging $13.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$698
  • Novo Nordisk$256
  • Pfizer$236
  • Lilly USA, LLC$161
  • Abbott$97
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$82
  • plus $522 from 18 others

What the payments were for

  • Food & beverage$2,052100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,052 in reported general payments places this provider in the 80th percentile of 4,119 family providers in Arizona.

See all family providers in Arizona

Medicare billing

Part B allowed, 2024
$41,871
Medicare patients
188
Services billed
798

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide25$25,415
OzempicSemaglutide13$19,526
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$4,836
Valsartan12$1,131
Atorvastatin Calcium117$1,109
Rosuvastatin Calcium52$1,020
Lisinopril115$925
Losartan Potassium36$909
Gabapentin29$762
Levothyroxine Sodium99$657
Albuterol Sulfate HfaAlbuterol Sulfate23$572
Pravastatin Sodium19$478
Omeprazole35$437
Fluoxetine Hcl36$396
Oxybutynin Chloride ErOxybutynin Chloride12$373

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$161$25,41525 claims
Novo NordiskOzempic$256$19,52613 claims
GSKAnoro Ellipta$53$4,83612 claims
Almatica Pharma LLCSertraline Hcl$21$20833 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,119 family providers in Arizona.

Other family in Chandler

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →